Research into GLP-1 medications, such as Ozempic and Wegovy, indicates they may play a role in reducing cancer risk by improving metabolic health, but the evidence remains mixed and further clinical trials are necessary to confirm these findings.
A recent study has found that elevated levels of glycoprotein acetyls (GlycA), a marker of systemic inflammation, are associated with a higher risk of cardiovascular events such a…
Ghana is confronting a public health crisis as the consumption of processed and ultra-processed foods rises, particularly among children and young people. This trend raises concer…
Access to obesity drugs in the UK is divided between a slow NHS rollout of tirzepatide and a rapidly growing private market. The NHS aims to provide access over 12 years, starting…
A recent study analyzed the prognostic associations of body mass index (BMI), waist circumference (WC), and body roundness index (BRI) in relation to major health outcomes among o…
Dozens of lawsuits have been filed against the manufacturers of GLP-1 drugs like Ozempic and Wegovy, alleging that users were not adequately warned about the risk of a rare type o…
MIT biologists have discovered a cellular pathway involving the protein YAP1 that is crucial for the metastasis of colorectal cancer. Their research indicates that a high-fat diet…
A recent study involving nearly 8.8 million adults indicates that consuming an additional 100 grams of ultra-processed foods daily is associated with heightened risks of cardiovas…
A recent systematic review and meta-analysis published on September 18, 2026, has found that sarcopenia, the age-related loss of muscle mass and strength, is associated with a 42%…
The Ministry of Health (MoH) and SEND Ghana are advocating for stronger measures to promote healthier food choices among children and young people, as unhealthy diets contribute t…
Roche has reported promising results from its mid-stage trial of enicepatide, an obesity drug that helped patients with type 2 diabetes achieve an average weight loss of 15.5% and…
A recent study published in Childhood Obesity highlights a concerning trend among children taking GLP-1 medications for weight management and diabetes. The study found that nearly…
A recent study published in The Lancet reveals that a strict regimen combining a low-calorie diet with supervised strength and aerobic training can help over half of younger adult…
Beauty industry leaders are ramping up efforts to develop treatments specifically designed for those experiencing facial volume loss, promising to redefine the standards of beauty…
The Trump administration has raised concerns about the testosterone levels of male service members, framing it as a national security issue. Senior Health and Human Services offic…
During a recent White House press briefing, JD Vance unveiled his astonishing weight loss secret while leaving officials and journalists alike bewildered at his audacity and physi…
Pfizer's stock is receiving a BUY rating from analysts, with a price target of $32.36, indicating a potential upside of 15%. The company has shown strong revenue performance and p…